Current Price Targets For Adamas Pharmaceuticals, Inc. (ADMS)
Recently stock market analysts have updated their consensus ratings on shares of Adamas Pharmaceuticals, Inc. (ADMS). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.
Most recent broker ratings
04/28/2016 – Adamas Pharmaceuticals, Inc. had its “neutral” rating reiterated by analysts at Mizuho. They now have a USD 17 price target on the stock.
04/01/2016 – JMP Securities began new coverage on Adamas Pharmaceuticals, Inc. giving the company a “market outperform” rating. They now have a USD 29 price target on the stock.
01/19/2016 – Cowen began new coverage on Adamas Pharmaceuticals, Inc. giving the company a “outperform” rating. They now have a USD 45 price target on the stock.
01/12/2016 – Adamas Pharmaceuticals, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 44 price target on the stock.
12/24/2015 – Adamas Pharmaceuticals, Inc. had its “outperform” rating reiterated by analysts at Credit Suisse. They now have a USD 37 price target on the stock.
12/23/2015 – Adamas Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 38 price target on the stock.
12/23/2015 – Aegis Capital began new coverage on Adamas Pharmaceuticals, Inc. giving the company a “buy” rating. They now have a USD 29 price target on the stock.
10/16/2015 – Adamas Pharmaceuticals, Inc. was downgraded to “sell” by analysts at TheStreet.
09/11/2015 – Adamas Pharmaceuticals, Inc. had its “outperform” rating reiterated by analysts at William Blair. They now have a USD 35 price target on the stock.
Adamas Pharmaceuticals, Inc. has a 50 day moving average of 16.27 and a 200 day moving average of 17.01. The stock’s market capitalization is 314.83M, it has a 52-week low of 12.02 and a 52-week high of 31.84.
The share price of the company (ADMS) was down -1.74% during the last trading session, with a high of 15.07 and the volume of Adamas Pharmaceuticals, Inc. shares traded was 243100.
View other investors thoughts on Adamas Pharmaceuticals, Inc. on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.